Nexia licenses Geron's nuclear transfer tech

Nexia (TSE:NXB) received a non-exclusive worldwide license to GERN's nuclear transfer patents to produce recombinant silk proteins, in return for cash, NXB equity and royalties. NXB is developing BioS...